This is a combination eye drop medicine. It uses two different ingredients to help lower eye pressure in glaucoma patients.
Every report comes from a Lived member, sent anonymously.
Have you tried Combigan (Brimonidine and Timolol) for Glaucoma?
Combigan is a prescription eye drop that combines two glaucoma medicines, brimonidine and timolol, in one bottle. It lowers the pressure inside the eye (intraocular pressure, or IOP) in people with glaucoma, a group of diseases that damage the optic nerve connecting the eye to the brain, and in people with ocular hypertension, which means raised eye pressure. Generic versions with the same two ingredients at the same strength are also available. It is approved for people whose eye pressure is not low enough on their current treatment, either as an added medicine or as a replacement for what they use now. Putting both drugs in one bottle means fewer drops each day than using brimonidine and timolol separately, although in studies the two separate bottles lowered pressure slightly more (by about 1 to 2 mm Hg, the unit eye pressure is measured in). It is approved for adults and for children aged 2 and older, but not for younger children.
The front of the eye is filled with a clear fluid that the eye produces continuously and drains away. When more fluid is made than drains, pressure rises, and higher pressure makes damage to the optic nerve more likely. That damage usually costs side (peripheral) vision first, and the higher the pressure, the greater the risk. The two ingredients lower pressure in different ways, which is why they are paired. Timolol is a beta-blocker, the same drug family as some heart and blood pressure pills; in the eye it appears to work mainly by reducing how much fluid is produced. Brimonidine is an alpha-2 agonist, a drug that activates a different set of nerve-signal receptors; it reduces fluid production and also helps fluid drain out through a second pathway. Each starts lowering pressure within an hour or two of a dose. Keeping pressure down is what helps slow glaucoma and protect the vision that remains.
Combigan contains 0.2% brimonidine and 0.5% timolol. The usual dose is one drop in each affected eye twice a day, about 12 hours apart, such as morning and evening. If other eye drops are also prescribed, wait at least 5 minutes between different products. Wash your hands, tilt your head back, pull down the lower lid to make a small pocket and let one drop fall in without the bottle tip touching the eye, lashes, fingers or anything else. A contaminated tip can cause a serious eye infection that threatens vision. Afterward, close the eye for 2 to 3 minutes and press gently on the inner corner, over the tear duct. The drops contain a preservative (benzalkonium chloride) that soft contact lenses can absorb, so take lenses out first and wait 15 minutes before putting them back in. Replace the cap after each use, and do not use the solution if it turns cloudy or changes color.
The most common effects are in the eye itself: redness, itching, burning or stinging, and allergic conjunctivitis (allergic irritation of the thin lining over the white of the eye and inside the lids). In year-long studies each of these affected roughly 5 to 15 out of 100 people. Less often, people notice dry or watery eyes, red or swollen eyelids, blurred vision, headache, dry mouth, tiredness or sleepiness. Some of each drop reaches the bloodstream, so timolol can act like a beta-blocker pill: it can slow the heart, lower blood pressure and narrow the airways. Report wheezing, chest tightness or new shortness of breath, a noticeably slow pulse, fainting, or new ankle swelling with breathlessness to the prescriber right away; severe trouble breathing needs emergency care. Brimonidine can also cause an eye allergy that sometimes comes with a rise in eye pressure, so redness, itching or lid swelling that keeps getting worse is worth reporting rather than putting up with.
Combigan is not used by people with asthma or a past history of asthma, or with severe chronic obstructive pulmonary disease (COPD, long-term lung disease such as emphysema), because timolol absorbed from eye drops has caused severe and occasionally fatal airway narrowing in people with asthma. People with milder COPD generally should not use it either. It is also not used with a slow heart rhythm (sinus bradycardia), more serious forms of heart block (an electrical problem that slows the heartbeat), overt heart failure or cardiogenic shock. It is not for infants and children under 2, because brimonidine has caused pauses in breathing, very slow heart rate, low body temperature and coma in infants; children aged 2 to 6 often become very sleepy on it. Tell the prescriber about every heart and blood pressure medicine you take, including beta-blocker pills such as metoprolol, calcium channel blockers (another family of heart and blood pressure drugs) and digoxin (a heart rhythm medicine), because the effects on heart rate and blood pressure can add up. Using two beta-blocker eye drops together is not recommended. Alcohol, sedatives, opioids and other drugs that cause drowsiness can add to brimonidine's sleepiness, and monoamine oxidase (MAO) inhibitors (an older type of antidepressant) may increase the chance of low blood pressure. In people with diabetes who use insulin or glucose-lowering pills, timolol can hide warning signs of low blood sugar, such as a fast heartbeat. It can also make epinephrine less effective in someone with a history of severe allergic reactions, worsen weakness in myasthenia gravis (a nerve and muscle disease) and add risk during general anesthesia, so surgical teams should know about it. Information on use in pregnancy is too limited to show whether there is a risk, and Combigan is not recommended while breastfeeding because timolol passes into breast milk and could affect a baby's breathing.
Pressure begins to fall within hours of a dose, but whether Combigan is working is judged at follow-up visits: tonometry (a quick measurement of eye pressure), examination of the optic nerve and visual field tests that map side vision. Most people feel no different as their pressure drops, because glaucoma often causes no symptoms at first. That is why the drops are used every day even when eyesight seems fine. Glaucoma has no cure, but it can usually be controlled, so for most people these drops are a long-term treatment rather than a short course. If pressure stays too high, or side effects such as eye allergy become a problem, the eye doctor may switch medicines or consider laser treatment or surgery. Do not stop the drops without talking to the eye doctor. Some people feel tired or drowsy on Combigan and should be careful with driving or other hazardous tasks until they know how it affects them. An eye injury, an eye infection or planned eye surgery is a reason to ask the eye doctor promptly whether to keep using the same bottle.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Combigan (Brimonidine and Timolol), what you've noticed, or ask the community a question.